BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 25779363)

  • 21. Survival differences between definitive radiotherapy and surgery followed by adjuvant radiotherapy in supraglottic and hypopharyngeal carcinoma.
    Zhang M; Gao XS; Qin Y; Sun Y; Ma MW
    Chin Med J (Engl); 2019 Nov; 132(22):2698-2704. PubMed ID: 31765356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment outcome in patients undergoing surgery for carcinoma larynx and hypopharynx: a follow-up study.
    Varghese BT; Sebastian P; Mathew A
    Acta Otolaryngol; 2009 Dec; 129(12):1480-5. PubMed ID: 19922101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Matched-pair analysis of patients with advanced hypopharyngeal cancer: surgery versus concomitant chemoradiotherapy.
    Iwae S; Fujii M; Hayashi R; Hasegawa Y; Fujii T; Okami K; Homma A; Onitsuka T; Kato T; Ogawa T; Terao K; Monden N; Otsuki N; Nishino H; Ota I; Fujimoto Y; Matsuura K; Kawabata K; Matsui H; Yonezawa K; Nibu KI
    Int J Clin Oncol; 2017 Dec; 22(6):1001-1008. PubMed ID: 28624863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prognostic factors affecting results of comprehensive treatment of hypopharyngeal carcinoma].
    Xu W; Lyu Z; Yang Z; Zou J; Cao H
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jul; 49(7):533-8. PubMed ID: 25257265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Final results of a randomized trial comparing chemotherapy plus radiotherapy with chemotherapy plus surgery plus radiotherapy in locally advanced resectable hypopharyngeal carcinomas.
    Beauvillain C; Mahé M; Bourdin S; Peuvrel P; Bergerot P; Rivière A; Vignoud J; Deraucourt D; Wesoluch M
    Laryngoscope; 1997 May; 107(5):648-53. PubMed ID: 9149168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Meta-analysis of comparison for efficacies between surgical plus radio(chemo)therapy and non-surgery chemoradiotherapy treatment strategies for advanced hypopharyngeal cancer].
    Fan JM; Wen SX; Wang BQ; Huangfu H; Zhai XS; Zhao XJ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Feb; 55(2):144-149. PubMed ID: 32074753
    [No Abstract]   [Full Text] [Related]  

  • 27. Cetuximab and Radiotherapy in Laryngeal Preservation for Cancers of the Larynx and Hypopharynx: A Secondary Analysis of a Randomized Clinical Trial.
    Bonner J; Giralt J; Harari P; Spencer S; Schulten J; Hossain A; Chang SC; Chin S; Baselga J
    JAMA Otolaryngol Head Neck Surg; 2016 Sep; 142(9):842-9. PubMed ID: 27389475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment sequence and survival in locoregionally advanced hypopharyngeal cancer: A surveillance, epidemiology, and end results-based study.
    Hochfelder CG; McGinn AP; Mehta V; Castellucci E; Kabarriti R; Ow TJ
    Laryngoscope; 2020 Nov; 130(11):2611-2621. PubMed ID: 31821572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancer.
    Zelefsky MJ; Kraus DH; Pfister DG; Raben A; Shah JP; Strong EW; Spiro RH; Bosl GJ; Harrison LB
    Head Neck; 1996; 18(5):405-11. PubMed ID: 8864731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemoradiotherapy versus surgery followed by postoperative radiotherapy in tonsil cancer: Korean Radiation Oncology Group (KROG) study.
    Song S; Wu HG; Lee CG; Keum KC; Kim MS; Ahn YC; Oh D; Park HJ; Lee SW; Park G; Moon SH; Cho KH; Kim YS; Won Y; Oh YT; Kim WT; Jeong JU
    BMC Cancer; 2017 Aug; 17(1):598. PubMed ID: 28854890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retrospective analysis of the clinical efficacy of definitive chemoradiotherapy for patients with hypopharyngeal cancer.
    Takehana K; Kodaira T; Tachibana H; Kimura K; Shimizu A; Makita C; Tomita N; Nishikawa D; Suzuki H; Hirakawa H; Hanai N; Hasegawa Y
    Jpn J Clin Oncol; 2016 Apr; 46(4):344-9. PubMed ID: 26826721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Organ preservation surgery for advanced hypopharyngeal cancer.
    Hirano S; Tateya I; Kitamura M; Kada S; Ishikawa S; Kanda T; Tanaka S; Ito J
    Acta Otolaryngol Suppl; 2010 Nov; (563):50-5. PubMed ID: 20879819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salvage circular laryngopharyngectomy and radial forearm free flap for recurrent hypopharyngeal cancer.
    Fakhry N; Chamorey E; Michel J; Collet C; Santini L; Poissonnet G; Santini J; Dessi P; Giovanni A; Dassonville O; Bozec A
    Laryngoscope; 2013 Apr; 123(4):910-5. PubMed ID: 23483475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial).
    Dietz A; Rudat V; Dreyhaupt J; Pritsch M; Hoppe F; Hagen R; Pfreundner L; Schröder U; Eckel H; Hess M; Schröder M; Schneider P; Jens B; Zenner HP; Werner JA; Engenhardt-Cabillic R; Vanselow B; Plinkert P; Niewald M; Kuhnt T; Budach W; Flentje M
    Eur Arch Otorhinolaryngol; 2009 Aug; 266(8):1291-300. PubMed ID: 18972123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival and Functional Outcome after Treatment for Primary Base of Tongue Cancer: A Comparison of Definitive Chemoradiotherapy versus Surgery Followed by Adjuvant Radiotherapy.
    Park S; Cho Y; Lee J; Koh YW; Kim SH; Choi EC; Kim HR; Keum KC; Park KR; Lee CG
    Cancer Res Treat; 2018 Oct; 50(4):1214-1225. PubMed ID: 29281874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypopharyngeal cancer treatment: Does initial surgery confer survival benefit?
    Tassler AB; Gooding WE; Ferris RL
    Head Neck; 2019 Jul; 41(7):2167-2173. PubMed ID: 30779398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-cycle induction chemotherapy for resectable advanced hypopharyngeal cancer.
    Nakashima T; Yasumatsu R; Asai K; Uryu H; Kogo R; Nakagawa T
    Int J Clin Oncol; 2017 Jun; 22(3):442-447. PubMed ID: 28062933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Induction chemotherapy and larynx preservation: is such practice useful?].
    Sarini J; Bocciolini C; Fournier C; Penel N; Kara A; Van JT; Lefebvre JL
    Bull Cancer; 2002 Apr; 89(4):411-7. PubMed ID: 12016041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of daily fraction size on laryngoesophageal dysfunction after chemoradiation for squamous cell carcinomas of the larynx and hypopharynx.
    Chen AM; Hsu S; Meshman J; Chin R; Beron P; Abemayor E; St John M
    Head Neck; 2017 Jul; 39(7):1322-1326. PubMed ID: 28301066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Definitive Chemoradiation in Locally Advanced Squamous Cell Carcinoma of the Hypopharynx: Long-term Outcomes and Toxicity.
    Juloori A; Koyfman SA; Geiger JL; Joshi NP; Woody NM; Burkey BB; Scharpf J; Lamarre EL; Prendes B; Adelstein DJ; Greskovich JF; Keller L
    Anticancer Res; 2018 Jun; 38(6):3543-3549. PubMed ID: 29848708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.